SYCP3: A Protein Potential Drug Target for Neurological Disorders

Target Name: SYCP3

NCBI ID: G50511

SYCP3

SYCP3: A Protein Potential Drug Target for Neurological Disorders

SYCP3 ( Short for Synaptotransmission-Specific Protein 3) is a protein that is expressed in the nervous system and has been identified as a potential drug target for the treatment of various neurological disorders. The protein is involved in the transmission of signals in the nervous system, which is critical for the function of the brain and the body.

SYCP3 is a transmembrane protein that is expressed in the dendrites of neurons and the cell body of neural circuits. It is composed of two main regions: an extracellular region that is involved in cell-cell signaling, and an intracellular region that is involved in intracellular signaling. The intracellular region of SYCP3 contains a unique protein that is involved in the regulation of ion channels, which are critical for the flow of electrical signals in the nervous system.

SYCP3 is a promising drug target because it is involved in the transmission of signals in the nervous system, which is critical for the function of the brain and the body. The abnormal functioning of SYCP3 has been implicated in a number of neurological disorders, including Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders.

One of the key challenges in the development of treatments for SYCP3-related disorders is the development of effective and safe drugs that can modulate the activity of the protein. Researchers have identified a number of potential drug candidates that target SYCP3, including small molecules, peptides, and antibodies. These drugs have the potential to treat a range of neurological disorders, including Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders.

In addition to its potential as a drug target, SYCP3 is also a potential biomarker for the diagnosis and progression of neurological disorders. The abnormal functioning of SYCP3 has been implicated in a number of neurological disorders, including Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders. By identifying individuals who have abnormal levels of SYCP3, researchers may be able to diagnose these disorders at an early stage and begin treatment.

Overall, SYCP3 is a protein that is involved in the transmission of signals in the nervous system and has the potential to be a drug target for the treatment of various neurological disorders. Further research is needed to fully understand the role of SYCP3 in the development of neurological disorders and to develop effective treatments.

Protein Name: Synaptonemal Complex Protein 3

Functions: Component of the synaptonemal complexes (SCS), formed between homologous chromosomes during meiotic prophase. Required for centromere pairing during meiosis in male germ cells (By similarity). Required for normal meiosis during spermatogenesis and male fertility (PubMed:14643120). Plays a lesser role in female fertility. Required for efficient phosphorylation of HORMAD1 and HORMAD2 (By similarity)

The "SYCP3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SYCP3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets